A method of treating a disease selected from the group consisting of Alzheimer's Disease, amyloid angiopathy, cerebral amyloid angiopathy, systemic amyloidosis, hereditary cerebral hemorrhage with amyloidosis of the Dutch type, inclusion body myositis, mild cognitive impairment (MCI) and Down's syndrome, in a subject, said method comprising administering a compound of formula Ia to said subject in an amount sufficient to alleviate the symptoms or progress of said disease, wherein said compound of formula (Ia) or a pharmaceutically acceptable salt, hydrate or prodrug thereof, is selected from the group consisting of (a) and (b)
- (a) a compound of the structure:
- wherein:
- R1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO2R5;
- R5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;
- R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
- R3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;
- R4 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, and substituted heterocycle;
- R6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
- W, X and Y are independently selected from the group consisting of CR7 and N;
- and
- R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl;
- and
- (b) a compound of the structure:
- wherein:
- R1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO2R5;
- R5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;
- R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
- R3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;
- R4 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, and substituted heterocycle;
- R6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
- W, X and Y are independently selected from the group consisting of CR7 and N;
- and
- R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl.